Mackenzie Financial’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.51M | Buy |
186,608
+17,778
| +11% | +$144K | ﹤0.01% | 894 |
|
|
2025
Q1 | $1.41M | Buy |
168,830
+156,609
| +1,281% | +$1.31M | ﹤0.01% | 881 |
|
|
2024
Q4 | $96.8K | Hold |
12,221
| – | – | ﹤0.01% | 1636 |
|
|
2024
Q3 | $102K | Sell |
12,221
-9,917
| -45% | -$82.5K | ﹤0.01% | 1477 |
|
|
2024
Q2 | $141K | Sell |
22,138
-848
| -4% | -$5.39K | ﹤0.01% | 1400 |
|
|
2024
Q1 | $139K | Buy |
22,986
+4,803
| +26% | +$29.1K | ﹤0.01% | 1395 |
|
|
2023
Q4 | $110K | Sell |
18,183
-2,936
| -14% | -$17.8K | ﹤0.01% | 1400 |
|
|
2023
Q3 | $91.7K | Sell |
21,119
-6,987
| -25% | -$30.3K | ﹤0.01% | 1355 |
|
|
2023
Q2 | $85.7K | Hold |
28,106
| – | – | ﹤0.01% | 1421 |
|
|
2023
Q1 | $39.1K | Hold |
28,106
| – | – | ﹤0.01% | 1455 |
|
|
2022
Q4 | $55.9K | Buy |
+28,106
| New | +$55.9K | ﹤0.01% | 1342 |
|
|
2020
Q2 | – | Sell |
-177,878
| Closed | -$619K | – | 1008 |
|
|
2020
Q1 | $619K | Buy |
+177,878
| New | +$619K | ﹤0.01% | 768 |
|